OTCMKTS:ACUS Acusphere (ACUS) Stock Price, News & Analysis → The 2024 Gold Rush: Unleashing Market Potential (From Priority Gold) (Ad) Free ACUS Stock Alerts $0.0001 0.00 (-90.00%) (As of 12/2/2021) Add Compare Share Share Today's Range$0.0001▼$0.000150-Day Range N/A52-Week Range$0.00▼$0.05Volume1,000 shsAverage Volume16,517 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Acusphere alerts: Email Address Ad The Freeport SocietyBill Clinton Backing Biden Replacement???Bill Clinton is back. And he just met in Mexico with the one person I believe could REPLACE Joe Biden by August…Click here now for my urgent election forecast. About Acusphere Stock (OTCMKTS:ACUS)Acusphere, Inc. operates as a specialty pharmaceutical company that develops and commercializes cardiovascular drugs. It offers Imagify (perflubutane polymer microspheres), a cardiovascular drug that evaluates myocardial perfusion and detects coronary artery disease. It provides Imagify as an injectable suspension. The company was formerly known as Polymers For Medicine, Inc. and changed its name to Acusphere, Inc. in March 2004. Acusphere, Inc. was founded in 1993 and is based in Watertown, Massachusetts.Read More ACUS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ACUS Stock News HeadlinesJuly 25, 2023 | investing.comGuizhou Aviation Technical Development Co Ltd (688239)June 24, 2023 | morningstar.comHealthcare StocksMay 13, 2024 | The Tomorrow Investor (Ad)The Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.May 16, 2023 | benzinga.comAcusphere Stock (OTC:ACUS), Insider Trading ActivityMarch 27, 2023 | marketwatch.comNanotechnology Market Size, Trends and Forecast 2030February 27, 2023 | marketwatch.comNanotechnology Market is Anticipated To Shown Growth by 2027February 19, 2023 | finance.yahoo.comAcusphere, Inc. (ACUS) Stock Historical Prices & Data - Yahoo FinanceJanuary 21, 2023 | finance.yahoo.comAcusphere, Inc. (ACUS)May 13, 2024 | The Tomorrow Investor (Ad)The Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.October 13, 2022 | reuters.comACUS.PK - Acusphere, Inc. | Stock Price & Latest News | ReutersOctober 4, 2022 | uk.finance.yahoo.comThe global contrast enhanced ultrasound market is expected to register a CAGR of 5.25% during the forecast period, 2022-2030July 13, 2022 | benzinga.comAcusphere (OTC:ACUS), Earnings Estimates, EPS, and RevenueJuly 6, 2022 | marketwatch.comNanotechnology Market Share 2022 Global Trend, Segmentation, Business Growth, Top Key Players Analysis Industry, Opportunities and Forecast to 2027March 26, 2022 | wsj.comAmarin Corp. PLC ADRFebruary 23, 2022 | apnews.comhC Bioscience Announces $24 Million Series A Financing to Develop Innovative Pipeline of Protein-Editing TherapiesJanuary 15, 2022 | msn.com10 Best Vibrating Massage Balls January 2022September 29, 2021 | prnewswire.comNeuroSense Therapeutics announces the appointment of Mark Leuchtenberger as Chairman of the BoardAugust 11, 2021 | barrons.comAcusphere Inc.See More Headlines Receive ACUS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Acusphere and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Today5/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:ACUS CUSIPN/A CIKN/A Webwww.acusphere.com Phone(617) 648-8800Fax978-863-9993Employees118Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable Beta-1.31 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesDr. William I. Ramage D.Phil (Age 70)Chief Development Officer Comp: $225.09kKey CompetitorsAbliva AB (publ)OTCMKTS:NEVPFAddex TherapeuticsOTCMKTS:ADDXFAeolus PharmaceuticalsOTCMKTS:AOLSAffymaxOTCMKTS:AFFYAlseres PharmaceuticalsOTCMKTS:ALSEView All Competitors ACUS Stock Analysis - Frequently Asked Questions How do I buy shares of Acusphere? Shares of ACUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ACUS) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersBill Clinton Backing Biden Replacement???The Freeport SocietyThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldThe A.I. story nobody is telling you (Read ASAP)TradeSmithGold Set to EXPLODE!Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Crypto 9-5 Escape PlanCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Acusphere, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
